Inventor · disambiguated record
Kent Bondensgaard
Also filed as: BONDENSGAARD KENT
11 granted patents·2 pending applications·114 citations·filing 2006–2020
90Inventor score
Top patents by PatentIndex Score
13 records- 0194US8470979B2Humanized antibody molecules specific for IL-31BONDENSGAARD KENT·Filed 2008·Granted Jun 25, 2013·40 cites·40 claims
- 0289US8034326B2IL-21 variantsNOVO NORDISK AS·Filed 2006·Granted Oct 11, 2011·18 cites·17 claims
- 0388US9416184B2Method of treating pruritus with IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2015·Granted Aug 16, 2016·5 cites·28 claims
- 0488US8685669B2Nucleic acid molecules encoding humanized antibody molecules specific for IL-31ZYMOGENETICS INC·Filed 2013·Granted Apr 1, 2014·7 cites·15 claims
- 0588US8211420B2Interleukin-21 variants with altered binding to the IL-21 receptorBONDENSGAARD KENT·Filed 2007·Granted Jul 3, 2012·30 cites·6 claims
- 0685US9005921B2Polynucleotides encoding IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2014·Granted Apr 14, 2015·5 cites·30 claims
- 0779US9982044B2Method of treating pruritus with IL-31 monoclonal antibody formulationsZYMOGENETICS INC·Filed 2017·Granted May 29, 2018·1 cites·24 claims
- 0877US9738715B2IL-31 monoclonal antibody formulationsZYMOGENETICS INC·Filed 2016·Granted Aug 22, 2017·1 cites·8 claims
- 0977US8475784B2IL-21 variantsHJORTH SIV ANNEGRETHE·Filed 2007·Granted Jul 2, 2013·7 cites·6 claims
- 1073US11542327B2Methods of treating pruritic disease with IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2020·Granted Jan 3, 2023·0 cites·28 claims
- 1170US10640559B2Nucleic acid molecules encoding humanized IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2018·Granted May 5, 2020·0 cites·10 claims
- 1245US2010249029A1Peptides with high affinity for the prolactin receptorNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 1330US2012107267A1Interleukin-21 variants having antagonistic binding to the il-21 receptorKANG LISHAN·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →